NCT05157945: An ongoing trial by Alto Neuroscience
This trial is completed, but has been granted a delay in reporting its results.
It must report results 1 day, 8 hours from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05157945 |
|---|---|
| Title | AN OPEN-LABEL STUDY OF ALTO-300 IN ADULTS WITH MAJOR DEPRESSIVE DISORDER |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Feb. 3, 2022 |
| Completion date | April 26, 2023 |
| Required reporting date | April 26, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | April 23, 2026 |
| Days late | None |